Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: Web-based Support to Manage Arthritis Pain [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating a web-based tool to help manage arthritis pain.
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2) [Phase 3]
This Phase 3 study evaluates subcutaneous golimumab added to DMARDs for rheumatoid arthritis, followed by an intravenous/subcutaneous golimu…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Co-Administration Of Methotrexate And CP-690,550 [Phase 1]
Phase 1 results report on co-administering methotrexate with CP-690,550 (tofacitinib) in rheumatoid arthritis; results were posted in Decemb…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA) [Phase 4]
Phase 4 study VISARA evaluated the effects of RoActemra/Actemra (tocilizumab) on immune responses to vaccination in patients with rheumatoid…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA) [Phase 3]
A Phase 3 trial evaluating changes in joint inflammation via ultrasonography in rheumatoid arthritis patients was terminated; results were p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care
This clinical trial update reports demographics, compliance, tolerability, and safety data for patients with rheumatoid arthritis, psoriatic…
-
FDA approval · 2012-12-04FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
FDA approved a supplemental application for Enbrel (etanercept) submitted by Immunex Corporation.
-
CLINICAL_TRIALS research · 2012-11-21Clinical Trial Update: Preliminary Study of Sonic Hedgehog Signaling Pathway in the Pathogenesis of Rheumatoid Arthritis
This document reports a preliminary clinical study investigating the Sonic Hedgehog signaling pathway in the pathogenesis of rheumatoid arth…
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Improvement of a Physically Active Lifestyle [NA]
A completed clinical trial investigating the impact of improving a physically active lifestyle on several conditions including osteoarthriti…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 3]
Phase 3 study evaluating tocilizumab's effect on markers of atherogenic risk in patients with moderate-to-severe rheumatoid arthritis; resul…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Rituximab for the Treatment of Early Rheumatoid Arthritis (RA) [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 evaluation of Rituximab for early rheumatoid arthritis; the trial was terminated and results …
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II [Phase 2]
A Phase II trial of HuMax-CD20 for active rheumatoid arthritis has completed. The study was sponsored by GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient [Phase 3]
Phase 3 clinical trial investigating corticosteroids and anti-TNF therapy in methotrexate-inadequate responder patients with rheumatoid arth…
-
FDA approval · 2012-11-06FDA Approved: XELJANZ — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved XELJANZ (tofacitinib) from Pfizer under its original application for rheumatoid arthritis, marking the initial approval of the …
-
CLINICAL_TRIALS trial_result · 2012-11-05Clinical Trial Update: Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA) [Phase 2]
Phase 2 single-dose trial of GW856553 in rheumatoid arthritis has completed, evaluating its effect on a disease biomarker.
-
FDA label_change · 2012-11-02FDA Approved: ARAVA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for ARAVA (leflunomide) submitted by Sanofi-aventis U.S. LLC.
-
CLINICAL_TRIALS withdrawal · 2012-10-31Clinical Trial Update: Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99
Expanded Access Trial of belimumab for rheumatoid arthritis is no longer available.
-
CLINICAL_TRIALS trial_result · 2012-10-22Clinical Trial Update: Effects Of Prednisolone On Rheumatoid Arthritis Patients
A completed clinical trial evaluated the effects of prednisolone in patients with rheumatoid arthritis, with results released as an update.
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: A Nutritional Intervention for Arthritis [NA]
A completed clinical trial (NCT01544101) evaluating a nutritional intervention for rheumatoid arthritis, sponsored by the Physicians Committ…
-
FDA approval · 2012-10-03FDA Approved: SULFASALAZINE — Supplemental Application (Sunrise Pharmaceutical, Inc.)
The FDA approved a supplemental application for sulfasalazine from Sunrise Pharmaceutical, Inc., marking an approval action for this generic…
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: N-3 PUFA and Rheumatoid Arthritis in Korea [NA]
A completed clinical trial in Korea evaluating N-3 PUFA (omega-3 polyunsaturated fatty acids) for rheumatoid arthritis has posted results.
-
FDA approval · 2012-10-01FDA Approved: OXAPROZIN — Supplemental Application (Chartwell RX, LLC.)
FDA approved a supplemental application for Oxaprozin filed by Chartwell RX, LLC., updating an existing approved generic oxaprozin product.
-
FDA approval · 2012-09-28FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for HUMIRA (adalimumab) submitted by Cordavis Limited.
-
FDA approval · 2012-09-28FDA Approved: INDOMETHACIN — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' indomethacin as an original ANDA (generic) application, making Indomethacin available as a generic …
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis [Phase 3]
Phase 3 trial evaluating certolizumab pegol added to methotrexate for rheumatoid arthritis, with results posted in 2012.